M&T Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.85M Sell
90,305
-11,574
-11% -$628K 0.01% 468
2026
Q1
$6.39M Sell
101,879
-1,234
-1% -$98.7K 0.02% 344
2025
Q4
$9.83M Buy
103,113
+22,214
+27% +$2.18M 0.03% 292
2025
Q3
$7.9M Sell
80,899
-27,565
-25% -$2.85M 0.03% 309
2025
Q2
$11.6M Buy
108,464
+6,701
+7% +$678K 0.04% 267
2025
Q1
$10.3M Sell
101,763
-10,320
-9% -$1.04M 0.04% 288
2024
Q4
$10M Buy
112,083
+5,956
+6% +$524K 0.03% 298
2024
Q3
$8.89M Buy
106,127
+370
+0.3% +$29.2K 0.03% 322
2024
Q2
$8.14M Buy
105,757
+6,086
+6% +$445K 0.03% 331
2024
Q1
$6.83M Sell
99,671
-1,925
-2% -$124K 0.02% 371
2023
Q4
$5.87M Sell
101,596
-2,887
-3% -$154K 0.02% 386
2023
Q3
$5.52M Sell
104,483
-2,526
-2% -$132K 0.02% 387
2023
Q2
$5.79M Sell
107,009
-3,072
-3% -$160K 0.02% 393
2023
Q1
$5.51M Buy
110,081
+22,347
+25% +$1.05M 0.02% 402
2022
Q4
$4.06M Sell
87,734
-5,272
-6% -$228K 0.02% 447
2022
Q3
$3.6M Sell
93,006
-895
-1% -$35.9K 0.02% 446
2022
Q2
$3.46M Buy
93,901
+2,424
+3% +$98.7K 0.02% 436
2022
Q1
$4.05M Sell
91,477
-12,041
-12% -$522K 0.02% 403
2021
Q4
$4.4M Sell
103,518
-8,398
-8% -$353K 0.02% 405
2021
Q3
$4.86M Buy
111,916
+310
+0.3% +$13.7K 0.02% 378
2021
Q2
$4.77M Sell
111,606
-7,481
-6% -$315K 0.02% 386
2021
Q1
$4.6M Buy
119,087
+16,346
+16% +$619K 0.02% 391
2020
Q4
$3.69M Sell
102,741
-14,994
-13% -$540K 0.02% 419
2020
Q3
$4.5M Sell
117,735
-2,278
-2% -$87.8K 0.02% 358
2020
Q2
$4.21M Buy
120,013
+1,001
+0.8% +$36K 0.02% 360
2020
Q1
$3.88M Buy
119,012
+128
+0.1% +$5K 0.02% 375
2019
Q4
$5.38M Buy
118,884
+1,595
+1% +$66.7K 0.03% 268
2019
Q3
$4.77M Buy
117,289
+1,250
+1% +$53K 0.02% 333
2019
Q2
$4.99M Buy
116,039
+303
+0.3% +$11.7K 0.03% 329
2019
Q1
$4.44M Buy
115,736
+9,780
+9% +$374K 0.02% 344
2018
Q4
$3.75M Buy
105,956
+9,865
+10% +$358K 0.02% 357
2018
Q3
$3.7M Sell
96,091
-8,983
-9% -$314K 0.02% 398
2018
Q2
$3.44M Sell
105,074
-623
-0.6% -$18.8K 0.02% 411
2018
Q1
$2.89M Buy
105,697
+7,948
+8% +$216K 0.02% 456
2017
Q4
$2.42M Buy
97,749
+8,688
+10% +$240K 0.01% 502
2017
Q3
$2.6M Buy
89,061
+7,994
+10% +$221K 0.01% 480
2017
Q2
$2.25M Buy
81,067
+1,656
+2% +$44K 0.01% 501
2017
Q1
$1.98M Buy
79,411
+971
+1% +$23.6K 0.01% 535
2016
Q4
$1.7M Buy
78,440
+1,786
+2% +$39K 0.01% 600
2016
Q3
$1.82M Sell
76,654
-11,269
-13% -$269K 0.01% 565
2016
Q2
$2.06M Sell
87,923
-2,838
-3% -$61.4K 0.01% 528
2016
Q1
$1.71M Sell
90,761
-27,496
-23% -$483K 0.01% 601
2015
Q4
$2.18M Sell
118,257
-336
-0.3% -$6.02K 0.01% 535
2015
Q3
$1.95M Buy
118,593
+69,731
+143% +$1.19M 0.01% 559
2015
Q2
$864K Buy
48,862
+17,937
+58% +$321K 0.01% 955
2015
Q1
$549K Buy
30,925
+889
+3% +$14.1K ﹤0.01% 1146
2014
Q4
$398K Sell
30,036
-6,272
-17% -$80.2K ﹤0.01% 1320
2014
Q3
$430K Buy
36,308
+35,908
+8,977% +$452K ﹤0.01% 1340
2014
Q2
$5K Hold
400
﹤0.01% 988
2014
Q1
$5K Hold
400
﹤0.01% 992
2013
Q4
$5K Hold
400
﹤0.01% 972
2013
Q3
$5K Buy
+400
New +$4.33K ﹤0.01% 917

Other funds holding BSX

M&T Bank's BSX Position: Q2 2026 in Review

M&T Bank reduced its Boston Scientific (BSX) stake by 11% in Q2 2026, selling an estimated $628K and leaving 90,305 shares worth $3.85M. The position accounts for 0.01% of the portfolio, ranked #468.

M&T Bank first reported a position in BSX in Q3 2013 and has held it in 52 quarters since. The position peaked at $11.6M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • M&T Bank held 90,305 shares of Boston Scientific worth $3.85M as of Q2 2026.
  • M&T Bank sold 11,574 Boston Scientific shares in Q2 2026, an estimated $628K.
  • Boston Scientific made up 0.01% of M&T Bank's portfolio in Q2 2026, its #468 holding.
  • M&T Bank first reported a position in Boston Scientific in Q3 2013 and has held it in 52 quarters since.
  • M&T Bank's Boston Scientific position peaked at $11.6M in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.